Why the study?
Does screening natriuretic peptide levels predict incident heart failure and death in individuals with type 1 and type 2 diabetes without known heart failure?
Does screening natriuretic peptide levels predict incident heart failure and death in individuals with type 1 and type 2 diabetes without known heart failure?
Answers are grounded in this paper and cite their sources.
This response reinforces the validity of using natriuretic peptide screening to predict incident heart failure in diabetic patients, defending against claims of short-term coding bias.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pop‐Busui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: